Endomorphins as Agents for the Treatment of Chronic Inflammatory Disease

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.3, 2006-01, pp. : 161-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sphingomyelinase Inhibition Suggests a Possible New Strategy for the Treatment of Inflammatory Bowel Disease

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 218-225

Bentham Science Publishers

Access to resources Recommend Favorite

State of the Art: Therapeutical Strategies for the Treatment of Inflammatory Bowel Disease

Current Drug Therapy, Vol. 8, Iss. 2, 2013-06 ,pp. : 99-120

Bentham Science Publishers

Access to resources Recommend Favorite

Probiotics and Inflammatory Bowel Disease

By Kwon J.H. Farrell R.J.

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 179-186

Adis International

Access to resources Recommend Favorite

Meta‐analysis and systematic review of procalcitonin‐guided treatment in acute exacerbation of chronic obstructive pulmonary disease

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 10-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

AIDS: The Making of a Chronic Disease

By BULLOUGH VERN L.

Nursing History Review, Vol. 3, Iss. 1, 1995-01 ,pp. : 264-266

Springer Publishing Company

Access to resources Recommend Favorite